InterGlobe Aviation Ltd INDIGO
NSE · India · Transportation
INR 4,929.90-54.10 (-1.09%)
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
MIAMI, September 29, 2026--Indigo, a vertically integrated, AI-driven medical professional liability platform, today announced that it has surpassed $20 million in premiums, doubling the company’s premium volume since announcing its $50 million Series B financing in January. The milestone reflects growing adoption among larger physician groups, continued expansion of Indigo’s curated broker network, and strong underwriting performance as the medical malpractice insurance market faces increasing
Oil just slipped back below the psychological $100 mark for Brent and $90 for WTI, easing some of the pressure that has stalked fuel intensive transport and logistics stocks in recent months. When a key input suddenly gets cheaper, cost structures can look very different, and that can shift how investors think about everything from airlines to freight operators. This article walks through 3 stocks from our Fuel intensive Transportation and Logistics Stocks screener that are directly exposed...
– New data from the Phase 3 INDIGO open-label extension will include the longer-term flare protection and safety data of obexelimab in IgG4-RD – – Additional analyses will assess glucocorticoid-associated toxicity and vaccine responses – WALTHAM, Mass., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company advancing therapies for patients living with autoimmune and inflammatory diseases, today announc
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.